STOCK TITAN

Sale of 1,464 IDXX (NASDAQ: IDXX) shares planned under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of IDXX common stock has filed a Rule 144 notice to sell 1,464 shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $920,293.11. Shares of common stock outstanding were 79,851,330 as of the filing.

The shares to be sold were acquired through restricted stock grants of 257 shares on 05/06/2024 and 262 shares on 05/06/2025, and a stock option exercise of 945 shares for cash on 02/17/2026, all from the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for IDXX disclose?

The Form 144 filing discloses a planned sale of 1,464 common shares of IDXX under Rule 144. The shares will be sold on the NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $920,293.11.

How many IDXX shares are planned to be sold and at what value?

The notice covers a proposed sale of 1,464 IDXX common shares with an aggregate market value of $920,293.11. This planned sale is to be executed on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

How were the IDXX shares in this Form 144 acquired?

The securities were acquired via restricted stock and a stock option exercise. The holder received 257 shares on 05/06/2024 and 262 shares on 05/06/2025 as restricted stock, plus 945 shares on 02/17/2026 through a cash stock option exercise.

What is the role of Morgan Stanley in the IDXX Form 144 filing?

Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker for the Rule 144 sale. The firm will handle the sale of 1,464 IDXX common shares on the NASDAQ on or about 02/17/2026, per the notice.

How many IDXX shares were outstanding when this Form 144 was filed?

The filing states that 79,851,330 common shares of IDXX were outstanding. This figure provides context for the planned Rule 144 sale of 1,464 shares, showing the transaction’s size relative to the total share count.

Does the Form 144 filer claim to have undisclosed adverse information on IDXX?

The person for whose account the securities will be sold represents that they do not know any material adverse information about IDXX’s current or prospective operations that has not been publicly disclosed, as required by the Rule 144 notice.
IDEXX Laboratories

NASDAQ:IDXX

IDXX Rankings

IDXX Latest News

IDXX Latest SEC Filings

IDXX Stock Data

49.76B
79.30M
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
WESTBROOK